Piekos Brian 4
4 · Gemini Therapeutics, Inc. /DE · Filed Oct 20, 2021
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2021-10-18+90,720→ 90,720 total→ Common Stock (90,720 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
- [F2]Thirty-three percent (33%) of the Restricted Stock Units shall vest upon the achievement of a clinical milestone, and the remaining sixty-seven percent (67%) of the Restricted Stock Units shall vest on the one (1)-year anniversary of the achievement of this clinical milestone.